Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Wait, you would know more as a Portuguese speaker than Scooter, shocking.
Thanks for confirming.
hahahhhhhahaha, goood one.
Agreed, easy for them to raise if neeeded.
that doesn't mean he is actually selling.
Yes. I think the reason for the $3.5M difference is that the secured notes are issued as OID (original issue discount), so the company gets $25M but pays back $28.5M
Ok, that makes sense. The aggregate value of the exercise price went to the Company. Thanks for the explanation.
The one thing that I don't understand in this whole explanation is the fact that all these options and warrants were exercised on a "cashless" basis. Which means that no cash was actually delivered to CYDY (holder gets credit for appreciated market value to pay the consideration to exercise these securities). So in order to follow the apparent explanation, the proceeds of the market sales of the shares would then have to have been given to CYDY. Was this then a loan, advance, gift, other?
Btw, I'm long, very long, and know how this stuff works, though I still don't understand what happened here.
No he didn't. Read my post. He has 90 days to sell but not an obligation to do so.
I checked it, the Form 144 is included there. ~4.8M shares. These haven't been sold, but the rules require for a Form 144 to be filed before any sales can take place. Doesn't mean that the shares will be sold, but he will have 90 days to sell them.
My read is that he will sell them to take care of tax obligations arising from the ~16m shares that he has.
Yes, this is exactly the reason. If an issuer doesn't file a proxy statement within 120 days of the end of its fiscal year, it will need to amend the 10-K to include the missing Part III info (executive comp, beneficial ownership, corporate governance, etc.). Nothing to see here, all standard stuff.
So in a way it would make sense for both parties to wait to settle until the 3 person appeal panel is announced, unless each side wants to derisk the chances of losing on appeal before then. AMRN has more to lose, so the price of settlement just went up and presumably AMRN should be favoring settlement more than the generics.
Sucks that we're even in this position, bad decision by the judge.
Think Equity, the underwriter of their Units public offering. Unfortunately I expect the price to drop given the offering and the propensity of shorts to short the hell out of these offerings. Once the price stabilizes, would be a great entry point.
Same here. Takes about 2-3 days for retail brokerage accounts. That’s why first couple of days of trading is all non-retail, shorts and those with smaller brokerages.
Very well said, completely agree.
You mean next Frost winner.
I saw it, but that doesn't mean anything. Obscure stock to buy by a random person who knows what a 13G is (likely filed by an attorney who the investor paid). Not saying good or bad investment, but just doesn't smell like a coincidence to me.
The only reason I think this person is not an idiot is because he or she was sophisticated enough to know to file a 13G. Normal people have no idea what a 13G is or when it needs to be filed.
Agreed, no $, means no success. I did the same research, but couldn't find anything. Let's see what happens.
New 13G filed. Can't find any more info on the holder. Looks like his or her first SEC filing ever under this name. Would seem kind of random for a person to just pickup more than 5% and then know that it would trigger the requirement to file a 13G. Must be a sophisticated investor. Wonder what prompted him or her to buy this position.
PR about the earnings dated should come out this week. I also will not be surprised if they go on a 5 day extension in light of the BS that's going on.
Citron's report is a bunch of steamy BS, more lies, misinformation, misdirection and grandiose accusations without facts. Citron has always made a killing on this template of an article since it is so difficult to sue them for it under US laws. They know they can get away with it, so continue to do so. They were sued and lost overseas.
100% agree with you.
right and pigs are going to fly tomorrow. This stock is going to rebound, great support and analyst coverage behind it. Real company as far as I can tell based on my research.
Zeno gets financing, $1.2M in tranches, making BIAD’s stake worth ~$7M. Good progress, wish it was only faster. https://ih.advfn.com/p.php?pid=nmona&article=78191021
Nice buy of Zeno, you're already making $. Good idea re Tom, maybe I will email him as well to congratulate.
Fantastic price rise for Zeno, we just need to wait until the public finds out that we own 60% of the technology. I picked up a few more shares.
Definitely still here, holding.
Just because they're registered, it doesn't mean they're selling. Key management will still have bunch of shares left and not registered. Everything seems to be going according to plan and the Company is developing very rapidly.
Second that, thank you for posting the update from Tom. We can wait a little longer :)
COCP acquired this note as part of Biozone sale. Now they are finally able to cash it in. Another $1.4M in cash to the company, that's key.
Thanks for contacting him. So so response despite the positive undertone. I guess we'll see what the near future brings.
Can someone reach out to Mr. Barr about this and any updates? I don't have his email.
We could all benefit from more info.
Thanks in advance.
ZENO is now at about $25M market cap and BIAD is still at $920,000. BIAD own 60%, ZENO owns 40%. What wrong with this picture?
Anticipated Closing Date is Dec 18th.
Second that, thank you as well.
Anyone buying more based on Zeno's latest PR?
This is one of the most idiotic statements I have read on this board for a while. Frost knows this business in and out and nobody has a better track record in biotech. Who are you going to replace him with?
They don't have a legal obligation to notify unless the officer is a CEO, CFO or a named executive officer. Russ is neither for Ekso. Take a look at their last 10-K to confirm and see his latest Form 4 below. Btw, I'm long and hold a sizeable position, but this was concerning to me.
1. Name and Address of Reporting Person *
Angold Russ 2. Issuer Name and Ticker or Trading Symbol
EKSO BIONICS HOLDINGS, INC. [ EKSO ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable)
_____ Director _____ 10% Owner
__ X __ Officer (give title below) _____ Other (specify below)
President, EksoWorks
(Last) (First) (Middle)
C/O EKSO BIONICS HOLDINGS, INC., 1414 HARBOUR WAY SOUTH, SUITE 1201 3. Date of Earliest Transaction (MM/DD/YYYY)
8/23/2017
(Street)
RICHMOND, CA 94804
(City) (State) (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)
Russ Angold - looks like he stepped down from his CTO role and is now the President of EksoWorks. This explains why he has sold more than 50% of his shares in the past couple of weeks. May be less involved with Ekso now. He was one of the original co-founders of Ekso and is a brilliant guy. Hope we don't lose him completely.